Staff

Director

Scott McNeil

Scott E. McNeil, PhD
Director

Dr. McNeil serves as the Director of the Nanotechnology Characterization Laboratory (NCL) for Leidos Biomedical Research and Frederick National Laboratory for Cancer Research, where he coordinates preclinical characterization of nanotech cancer therapeutics and diagnostics.

Read More

 

Pharmacology & Toxicology

Stephan Stern

Stephan T. Stern, PhD, DABT
Sr. Principal Scientist, Pharmacology & Toxicology

Dr. Stern is actively involved in applied nanomaterial research, and has published numerous articles on nanomaterial toxicology and pharmacokinetics in leading scientific journals.

Read More

Abdullah Mahmud, PhD
Scientist II, Pharmacology & Toxicology

Dr. Mahmud joined the Nanotechnology Characterization Laboratory (NCL) as a Formulation Scientist in October 2011. His responsibilities include development and reformulation of existing anticancer drugs using novel nanotechnology based delivery technologies.

Read More

David Stevens

David Stevens, PhD
Scientist I, Pharmacology & Toxicology

Dr. Stevens develops novel drug formulation strategies including micelle formulations and polymeric prodrugs for the improved delivery of small molecule chemotherapeutics.

Read More

Sarah Skoczen

Sarah Skoczen, MS
Research Associate III, Pharmacology & Toxicology

Ms. Skoczen joined the NCL in September of 2005, as a Research Assistant. She is responsible for helping maintain human and animal primary and immortalized cells.

Read More

Kelsie Snapp

Kelsie Snapp, BS, MBA
Research Associate I, Pharmacology & Toxicology

Kelsie’s role at the NCL involves working with bioanalytical assays and helping to develop methods for measuring nanoparticle drug release for the pharmacology and toxicology section.

Read More

 

Immunology

Marina Dobrovolskaia

Marina A. Dobrovolskaia, PhD, MBA
Sr. Principal Scientist, Immunology

Dr. Dobrovolskaia is a Senior Principal Scientist and Head of the Immunology Section at the Nanotechnology Characterization Laboratory (NCL). 

Read More

Enping Hong

Enping Hong, PhD
Post-Doctoral Fellow, Immunology

At the NCL, Dr. Hong studies the mechanisms of inflammation instigated by novel nucleic acid-based nanoparticles, and also investigates the immunotherapeutic potential of nanoparticles for peptide delivery.

Read More

Ankit Shah

Ankit Shah, PhD
Post-Doctoral Fellow, Immunology

Dr. Shah joined the NCL as a post-doctoral fellow in the immunology section in July 2016. His studies are focused on the immunotoxicities associated with nanoparticles. In particular, he is interested in understanding the immune responses and the underlying molecular mechanisms resulting from iron oxide nanoparticles.

Read More

Barry Neun

Barry Neun, BS
Research Associate III, Immunology

Mr. Neun is the primary technician responsible for endotoxin and sterility pre-screening of all materials submitted to the NCL. 

Read More

Edward Cedrone

Edward Cedrone, BS
Research Associate I, Immunology

Mr. Cedrone’s main role at the NCL is assessing nanoparticle effects on immune cell function by conducting in vitro and in vivo cell-based immune assays. Edward brings a wealth of experience in cell and tissue culture from his previous employment at the Cell Biology Program of the American Type Culture Collection (ATCC) in Manassas, Virginia.

Read More

 

Physicochemical Characterization

Jeffrey Clogston

Jeffrey D. Clogston, PhD
Principal Scientist, Physicochemical Characterization

Dr. Clogston joined the Nanotechnology Characterization Laboratory (NCL) as a Scientist in March 2006. In his position, Dr. Clogston conducts physico-chemical characterization and standardization of nanoparticles intended for cancer therapeutics and diagnostics.

Read More

Jiewei Wu

Jiewei Wu
Scientist I, Physicochemical Characterization

Dr. Wu joined the NCL as a Scientist in August 2016. Her efforts are focused on the physicochemical characterization of nanoparticles, the development of new analytical methods for nanomedicine evaluation, and chemical synthesis and nanoformulation.

Read More

Sonny Man

Sonny Man, MS
Research Associate II, Physicochemical Characterization

Sonny Man joined the NCL in August of 2008 as a research associate. He is involved in the synthesis of nanomaterials intended for cancer therapeutics and diagnostics.

Read More

Alison Vermilya

Alison Vermilya, MS
Research Associate I, Physicochemical Characterization

Mrs. Vermilya assists in the physicochemical characterization of nanoparticles that are studied at the NCL, including transmission electron microscopy (TEM) imaging and size analysis, dynamic light scattering (DLS), and zeta potential measurements.

Read More

Cassandra Mankus

Cassandra Mankus, BS
Research Associate I, Physicochemical Characterization

Cassandra Mankus joined the NCL in July 2016. She works in support of the physicochemical characterization of nanoparticles.

Read More

 

Cancer Biology

Pavan Adiseshaiah

Pavan Adiseshaiah, PhD
Sr. Scientist, Cancer Biology

At the Nanotechnology Characterization Laboratory, Dr. Adiseshaiah will be responsible in the experimental design, implementation and analysis of in vivo oncology studies to characterize nanomaterials for therapeutics and diagnostics.

Read More

Bhawna Sharma

Bhawna Sharma, PhD
Post-Doctoral Fellow, Cancer Biology

Dr. Sharma joined the NCL in 2016 as a postdoctoral fellow in the Cancer Biology Section. Her work involves investigating the role of nanoparticles in cancer therapy and inflammasome activation.

Read More

Timothy Potter

Timothy Potter, BS
Research Associate III, Cancer Biology

Mr. Potter is the primary tissue culture technician for the NCL, maintaining human and animal primary and immortalized cells. His duties include running a variety of cell-based toxicity and immunology assays and working closely with other NCL personnel in assay development.

Read More

Travis Kerr

Travis Kerr, MS
Research Associate I, Cancer Biology

Travis joined the Cancer Biology section of the NCL in October 2016 as a Research Associate I. His duties include maintaining the tissue culture laboratory, both human and animal primary and immortalized cells, and running cytotoxicity assays (e.g. MTT and LDH) as part of the assay cascade for the characterization of nanomaterials.

Read More

 

Alliance Management

Jennifer Grossman

Jennifer Grossman, PhD
Sr. Scientist, Alliance Management

Dr. Grossman leads NCL's Alliance Management Division, which has established and managed productive collaborations within NCI, FDA, NIST and a network of over 150 drug development labs in industry and academia. 

Read More

Rachael M. Crist

Rachael M. Crist, PhD
Scientist II, Alliance Management

Dr. Crist is a Scientist II in NCL’s Alliance Management Division, part of a team of scientists responsible for managing the NCL’s external collaborations with academic and pharmaceutical organizations from around the globe, as well as interfacing with various agencies within the US Government. 

Read More

Maggie Scully

Maggie Scully, PhD
Scientist I, Alliance Management

Maggie is a Technical Writer and part of the Alliance Management team aimed at providing clear communications among NCL and its collaborators. Prior to this position, Dr. Scully spent over 9 years at the laboratory bench engineering and validating nanoparticles for drug delivery and imaging applications, predominantly for cancer.

Read More

 

HQ Support

Christopher McLeland

Christopher McLeland, BS, MBA
Associate Scientist, HQ Support

Chris McLeland joined the Nanotechnology Characterization Laboratory in October of 2004 as a Senior Research Associate. Mr. McLeland functions as the laboratory manager by providing financial analysis, logistical coordination, and technical support to team members.

Read More

Jaime Rodriguez

Jamie Rodriguez, BS
Research Associate II, HQ Support

Mrs. Rodriguez joined the NCL as a Research Technician in January 2007. 

Read More

Becky Schneider

Becky Schneider, BS
Administrative Assistant, HQ Support

Becky Schneider joined the Nanotechnology Characterization Laboratory in 2013 as the lab’s administrative professional. In her position, she provides administrative support to the lab’s Director and staff members, as well as liaise with staff from the National Cancer Institute’s Office of Cancer Nanotechnology Research.

Read More